Horizon Therapeutics Public Ltd Co

STATE STREET CORP

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

5,233,927

Value ($000)

605,513

Weight

0.0%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	605,513	0.0%	5,233,927	9/30/2023
2023 Q2	8/14/2023	542,436	0.0%	5,274,052	6/30/2023
2023 Q1	5/15/2023	558,997	0.0%	5,121,833	3/31/2023
2022 Q4	5/15/2023	602,721	0.0%	5,296,318	12/31/2022
2022 Q3	11/15/2022	354,777	0.0%	5,732,387	9/30/2022
2022 Q2	8/15/2022	442,187	0.0%	5,543,974	6/30/2022
2022 Q1	5/16/2022	576,388	0.0%	5,478,453	3/31/2022
2021 Q4	2/14/2022	589,911	0.0%	5,474,308	12/31/2021
2021 Q3	11/15/2021	596,119	0.0%	5,442,017	9/30/2021
2021 Q2	8/16/2021	510,424	0.0%	5,450,915	6/30/2021
2021 Q1	7/9/2021	401,997	0.0%	4,367,633	3/31/2021
2020 Q4	2/16/2021	322,956	0.0%	4,414,988	12/31/2020
2020 Q3	11/10/2020	194,045	0.0%	2,498,003	9/30/2020
2020 Q2	8/14/2020	140,450	0.0%	2,526,987	6/30/2020
2020 Q1	6/19/2020	78,932	0.0%	2,664,837	3/31/2020
2019 Q4	2/6/2020	94,030	0.0%	2,597,510	12/31/2019